168 related articles for article (PubMed ID: 34762897)
1. Netrin-like domain of sFRP4, a Wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG.
Yasmin IA; Mohana Sundaram S; Banerjee A; Varier L; Dharmarajan A; Warrier S
Exp Cell Res; 2021 Dec; 409(2):112912. PubMed ID: 34762897
[TBL] [Abstract][Full Text] [Related]
2. Short peptide domains of the Wnt inhibitor sFRP4 target ovarian cancer stem cells by neutralizing the Wnt β-catenin pathway, disrupting the interaction between β-catenin and CD24 and suppressing autophagy.
Sundaram SM; Varier L; Fathima KZ; Dharmarajan A; Warrier S
Life Sci; 2023 Mar; 316():121384. PubMed ID: 36646377
[TBL] [Abstract][Full Text] [Related]
3. The role of the cysteine-rich domain and netrin-like domain of secreted frizzled-related protein 4 in angiogenesis inhibition in vitro.
Longman D; Arfuso F; Viola HM; Hool LC; Dharmarajan AM
Oncol Res; 2012; 20(1):1-6. PubMed ID: 23035359
[TBL] [Abstract][Full Text] [Related]
4. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition.
Warrier S; Bhuvanalakshmi G; Arfuso F; Rajan G; Millward M; Dharmarajan A
Cancer Gene Ther; 2014 Sep; 21(9):381-8. PubMed ID: 25104726
[TBL] [Abstract][Full Text] [Related]
6. Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.
Bhuvanalakshmi G; Arfuso F; Millward M; Dharmarajan A; Warrier S
PLoS One; 2015; 10(6):e0127517. PubMed ID: 26030909
[TBL] [Abstract][Full Text] [Related]
7. The Wnt regulator SFRP4 inhibits mesothelioma cell proliferation, migration, and antagonizes Wnt3a via its netrin-like domain.
Perumal V; Dharmarajan AM; Fox SA
Int J Oncol; 2017 Jul; 51(1):362-368. PubMed ID: 28534940
[TBL] [Abstract][Full Text] [Related]
8. Number and brightness analysis of sFRP4 domains in live cells demonstrates vesicle association signal of the NLD domain and dynamic intracellular responses to Wnt3a.
Perumal V; Krishnan K; Gratton E; Dharmarajan AM; Fox SA
Int J Biochem Cell Biol; 2015 Jul; 64():91-6. PubMed ID: 25805505
[TBL] [Abstract][Full Text] [Related]
9. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
[TBL] [Abstract][Full Text] [Related]
10. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells.
Dong Z; Zhou L; Han N; Zhang M; Lyu X
Strahlenther Onkol; 2015 Aug; 191(8):672-80. PubMed ID: 26072169
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.
Wu Q; Yin X; Zhao W; Xu W; Chen L
PLoS One; 2021; 16(12):e0260864. PubMed ID: 34852024
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/
Ji J; You Q; Zhang J; Wang Y; Cheng J; Huang X; Zhang Y
Anal Cell Pathol (Amst); 2021; 2021():8980711. PubMed ID: 34926132
[TBL] [Abstract][Full Text] [Related]
14. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.
Chen X; Hu W; Xie B; Gao H; Xu C; Chen J
Biochem Biophys Res Commun; 2014 May; 448(2):206-11. PubMed ID: 24785374
[TBL] [Abstract][Full Text] [Related]
16. Cyclophilin A Maintains Glioma-Initiating Cell Stemness by Regulating Wnt/β-Catenin Signaling.
Wang G; Shen J; Sun J; Jiang Z; Fan J; Wang H; Yu S; Long Y; Liu Y; Bao H; Zhang KX; Han K; Zhu M; Zheng Y; Lin Z; Jiang C; Guo M
Clin Cancer Res; 2017 Nov; 23(21):6640-6649. PubMed ID: 28790108
[No Abstract] [Full Text] [Related]
17. Secreted Frizzled-related protein 4 (sFRP4) chemo-sensitizes cancer stem cells derived from human breast, prostate, and ovary tumor cell lines.
Deshmukh A; Kumar S; Arfuso F; Newsholme P; Dharmarajan A
Sci Rep; 2017 May; 7(1):2256. PubMed ID: 28536422
[TBL] [Abstract][Full Text] [Related]
18. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
19. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
[TBL] [Abstract][Full Text] [Related]
20. The miR-181a-SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer.
Belur Nagaraj A; Knarr M; Sekhar S; Connor RS; Joseph P; Kovalenko O; Fleming A; Surti A; Nurmemmedov E; Beltrame L; Marchini S; Kahn M; DiFeo A
Cancer Res; 2021 Apr; 81(8):2044-2055. PubMed ID: 33574092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
